Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK.
Lippman SM, et al. Among authors: lotan r.
J Natl Cancer Inst. 2001 Apr 18;93(8):605-18. doi: 10.1093/jnci/93.8.605.
J Natl Cancer Inst. 2001.
PMID: 11309437
Clinical Trial.